Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria

Gram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a result of intestinal translocation during neutropenia. In this study we sought to better understand how the composition of the intestinal micro...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 73; no. 11; pp. e4627 - e4635
Main Authors Stoma, Igor, Littmann, Eric R, Peled, Jonathan U, Giralt, Sergio, van den Brink, Marcel R M, Pamer, Eric G, Taur, Ying
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 06.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Gram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a result of intestinal translocation during neutropenia. In this study we sought to better understand how the composition of the intestinal microbiota is connected to risk of gram-negative BSIs, expanding on our prior work in these patients. Fecal specimens were collected from recipients of allo-HCT and analyzed using 16S ribosomal RNA gene sequencing. Samples and clinical data extending from the pretransplant conditioning period through stem cell engraftment were used in the analysis. Intestinal domination (relative abundance ≥ 30%) by gram-negative bacteria was used as predictor of gram-negative BSI using Cox proportional hazards modeling. Further analysis of microbiota composition was performed at the genus level. Seven hundred eight allo-HCT subjects were studied (7.5% developed gram-negative infection), with 4768 fecal samples for analysis. Gram-negative intestinal domination was associated with subsequent BSI, which was observed overall and individually at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas. Fluoroquinolone prophylaxis was associated with decreased BSI and intestinal colonization by gram-negative microbes. In fluoroquinolone-prophylaxed patients, Escherichia coli was more frequently observed as breakthrough, both in terms of intestinal colonization and BSIs, compared with nonprophylaxed patients. Initial colonization by members of Ruminococcaceae and Bacteroidetes were associated with protection against gram-negative BSI. Gram-negative intestinal colonization is highly predictive of BSI in the setting of allo-HCT. Fluoroquinolones appear to reduce these infections by influencing gut colonization.
AbstractList In this study, the intestinal microbiota and risk of gram-negative bloodstream infections was studied in patients undergoing allogeneic hematopoietic cell transplantation, during neutropenia. Expansion and domination by gram negatives occur in these patients and are predictive of bloodstream infection.
Gram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a result of intestinal translocation during neutropenia. In this study we sought to better understand how the composition of the intestinal microbiota is connected to risk of gram-negative BSIs, expanding on our prior work in these patients.BACKGROUNDGram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a result of intestinal translocation during neutropenia. In this study we sought to better understand how the composition of the intestinal microbiota is connected to risk of gram-negative BSIs, expanding on our prior work in these patients.Fecal specimens were collected from recipients of allo-HCT and analyzed using 16S ribosomal RNA gene sequencing. Samples and clinical data extending from the pretransplant conditioning period through stem cell engraftment were used in the analysis. Intestinal domination (relative abundance ≥ 30%) by gram-negative bacteria was used as predictor of gram-negative BSI using Cox proportional hazards modeling. Further analysis of microbiota composition was performed at the genus level.METHODSFecal specimens were collected from recipients of allo-HCT and analyzed using 16S ribosomal RNA gene sequencing. Samples and clinical data extending from the pretransplant conditioning period through stem cell engraftment were used in the analysis. Intestinal domination (relative abundance ≥ 30%) by gram-negative bacteria was used as predictor of gram-negative BSI using Cox proportional hazards modeling. Further analysis of microbiota composition was performed at the genus level.Seven hundred eight allo-HCT subjects were studied (7.5% developed gram-negative infection), with 4768 fecal samples for analysis. Gram-negative intestinal domination was associated with subsequent BSI, which was observed overall and individually at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas. Fluoroquinolone prophylaxis was associated with decreased BSI and intestinal colonization by gram-negative microbes. In fluoroquinolone-prophylaxed patients, Escherichia coli was more frequently observed as breakthrough, both in terms of intestinal colonization and BSIs, compared with nonprophylaxed patients. Initial colonization by members of Ruminococcaceae and Bacteroidetes were associated with protection against gram-negative BSI.RESULTSSeven hundred eight allo-HCT subjects were studied (7.5% developed gram-negative infection), with 4768 fecal samples for analysis. Gram-negative intestinal domination was associated with subsequent BSI, which was observed overall and individually at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas. Fluoroquinolone prophylaxis was associated with decreased BSI and intestinal colonization by gram-negative microbes. In fluoroquinolone-prophylaxed patients, Escherichia coli was more frequently observed as breakthrough, both in terms of intestinal colonization and BSIs, compared with nonprophylaxed patients. Initial colonization by members of Ruminococcaceae and Bacteroidetes were associated with protection against gram-negative BSI.Gram-negative intestinal colonization is highly predictive of BSI in the setting of allo-HCT. Fluoroquinolones appear to reduce these infections by influencing gut colonization.CONCLUSIONSGram-negative intestinal colonization is highly predictive of BSI in the setting of allo-HCT. Fluoroquinolones appear to reduce these infections by influencing gut colonization.
Gram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a result of intestinal translocation during neutropenia. In this study we sought to better understand how the composition of the intestinal microbiota is connected to risk of gram-negative BSIs, expanding on our prior work in these patients. Fecal specimens were collected from recipients of allo-HCT and analyzed using 16S ribosomal RNA gene sequencing. Samples and clinical data extending from the pretransplant conditioning period through stem cell engraftment were used in the analysis. Intestinal domination (relative abundance ≥ 30%) by gram-negative bacteria was used as predictor of gram-negative BSI using Cox proportional hazards modeling. Further analysis of microbiota composition was performed at the genus level. Seven hundred eight allo-HCT subjects were studied (7.5% developed gram-negative infection), with 4768 fecal samples for analysis. Gram-negative intestinal domination was associated with subsequent BSI, which was observed overall and individually at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and Stenotrophomonas. Fluoroquinolone prophylaxis was associated with decreased BSI and intestinal colonization by gram-negative microbes. In fluoroquinolone-prophylaxed patients, Escherichia coli was more frequently observed as breakthrough, both in terms of intestinal colonization and BSIs, compared with nonprophylaxed patients. Initial colonization by members of Ruminococcaceae and Bacteroidetes were associated with protection against gram-negative BSI. Gram-negative intestinal colonization is highly predictive of BSI in the setting of allo-HCT. Fluoroquinolones appear to reduce these infections by influencing gut colonization.
Author Littmann, Eric R
Peled, Jonathan U
Stoma, Igor
Giralt, Sergio
Pamer, Eric G
Taur, Ying
van den Brink, Marcel R M
AuthorAffiliation 3 Adult Bone Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center , New York, New York , USA
4 Weill Cornell Medical College , New York, New York , USA
2 Department of Infectious Diseases, Belarusian State Medical University , Minsk , Belarus
5 Infectious Diseases Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center , New York, New York , USA
1 Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center , New York, New York , USA
AuthorAffiliation_xml – name: 2 Department of Infectious Diseases, Belarusian State Medical University , Minsk , Belarus
– name: 5 Infectious Diseases Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center , New York, New York , USA
– name: 3 Adult Bone Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center , New York, New York , USA
– name: 4 Weill Cornell Medical College , New York, New York , USA
– name: 1 Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center , New York, New York , USA
Author_xml – sequence: 1
  givenname: Igor
  surname: Stoma
  fullname: Stoma, Igor
  organization: Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Department of Infectious Diseases, Belarusian State Medical University, Minsk, Belarus
– sequence: 2
  givenname: Eric R
  surname: Littmann
  fullname: Littmann, Eric R
  organization: Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA
– sequence: 3
  givenname: Jonathan U
  surname: Peled
  fullname: Peled, Jonathan U
  organization: Adult Bone Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Weill Cornell Medical College, New York, New York, USA
– sequence: 4
  givenname: Sergio
  surname: Giralt
  fullname: Giralt, Sergio
  organization: Adult Bone Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Weill Cornell Medical College, New York, New York, USA
– sequence: 5
  givenname: Marcel R M
  surname: van den Brink
  fullname: van den Brink, Marcel R M
  organization: Adult Bone Marrow Transplantation Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Weill Cornell Medical College, New York, New York, USA
– sequence: 6
  givenname: Eric G
  surname: Pamer
  fullname: Pamer, Eric G
  organization: Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Weill Cornell Medical College, New York, New York, USA, Infectious Diseases Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA
– sequence: 7
  givenname: Ying
  orcidid: 0000-0002-6601-8284
  surname: Taur
  fullname: Taur, Ying
  organization: Center for Microbes, Inflammation and Cancer, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Weill Cornell Medical College, New York, New York, USA, Infectious Diseases Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, New York, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31976518$$D View this record in MEDLINE/PubMed
BookMark eNptkd1LHTEQxUNR6kd96nvJY0G2Jpv9yL4U6kWtoAjS4mOYzU680d3kNskV-983W69iiw8hYeaXM8M5e2TLeYeEfOTsC2edONJ2yAeANfId2eW1aIum7vhWfrNaFpUUcofsxXjHGOeS1e_JjuBd29Rc7pKw8NPKR5usdzDS03H9SG9sWlpH0xLpuUsYk51bl1YH31ufgIIb6LWN99T4QI9H74eYAsKUcYN6lvqrQc8CTIXDW0j2Aekx6ITBwgeybWCMeLC598nP05Mfi-_FxdXZ-eLbRaGF5KnooSrlMMi-bLED0zPDeDOgKLFEzQ1WIHLNIAytFD0Ko4XooazavtNdWxqxT74-6a7W_YSDRpcCjGoV7ATht_Jg1b8dZ5fq1j8o2TRlK7ss8HkjEPyvdfZBTTZqHEdw6NdRlaLKKzImZvTT61kvQ56NzsDhE5BNjDGgeUE4U3OMKseoNjFmmv9Ha5tgNjYvasc3__wBnU6mVw
CitedBy_id crossref_primary_10_1016_j_lfs_2023_121993
crossref_primary_10_1016_j_trsl_2020_07_002
crossref_primary_10_1111_apm_13208
crossref_primary_10_1007_s00383_023_05555_2
crossref_primary_10_1080_19490976_2024_2340486
crossref_primary_10_1093_cid_ciac299
crossref_primary_10_1158_1078_0432_CCR_22_1254
crossref_primary_10_1111_tid_14152
crossref_primary_10_1016_j_chom_2023_03_002
crossref_primary_10_1128_spectrum_02728_21
crossref_primary_10_3389_fmicb_2024_1407324
crossref_primary_10_1182_blood_2020006923
crossref_primary_10_1007_s10555_022_10033_7
crossref_primary_10_1016_j_cell_2023_05_007
crossref_primary_10_1080_19490976_2022_2038856
crossref_primary_10_1186_s40001_021_00508_8
crossref_primary_10_1038_d41586_024_02803_w
crossref_primary_10_1016_j_epidem_2025_100817
crossref_primary_10_1093_cid_ciab1043
crossref_primary_10_1007_s12275_024_00190_5
crossref_primary_10_1016_j_mib_2020_05_004
crossref_primary_10_1038_s41598_022_10282_0
crossref_primary_10_1038_s41579_021_00667_9
crossref_primary_10_3389_frtra_2024_1400067
crossref_primary_10_1182_bloodadvances_2023009960
crossref_primary_10_1080_19490976_2024_2423026
crossref_primary_10_21294_1814_4861_2024_23_6_51_61
crossref_primary_10_1177_20499361211053480
crossref_primary_10_3389_fimmu_2023_1139821
crossref_primary_10_1080_19490976_2023_2229567
crossref_primary_10_1016_j_gde_2020_11_007
crossref_primary_10_1080_26895293_2022_2074546
crossref_primary_10_1080_19490976_2021_1939599
crossref_primary_10_1128_spectrum_00415_23
crossref_primary_10_3390_antibiotics11020217
crossref_primary_10_1016_j_chemosphere_2022_135558
crossref_primary_10_3389_fimmu_2024_1266579
crossref_primary_10_1038_s41564_024_01680_3
crossref_primary_10_3390_jcm13206082
crossref_primary_10_3390_antibiotics13050448
crossref_primary_10_1128_mSphere_00500_21
crossref_primary_10_1002_cncr_34091
crossref_primary_10_1016_j_chom_2023_05_027
crossref_primary_10_1200_JCO_23_01169
crossref_primary_10_1128_msphere_00450_20
crossref_primary_10_1016_j_chom_2023_11_016
crossref_primary_10_1146_annurev_micro_041020_022206
crossref_primary_10_51523_2708_6011_2021_18_3_20
crossref_primary_10_1080_19490976_2024_2351478
crossref_primary_10_1038_s41564_021_00989_7
crossref_primary_10_1097_MCC_0000000000001019
crossref_primary_10_1038_s41597_022_01302_9
crossref_primary_10_1155_2023_3532756
crossref_primary_10_1016_S1473_3099_22_00811_8
crossref_primary_10_2147_IDR_S280869
crossref_primary_10_3390_ijms23020803
crossref_primary_10_2147_IDR_S387615
crossref_primary_10_1093_cid_ciaa846
crossref_primary_10_1038_s43018_023_00669_x
crossref_primary_10_1371_journal_pone_0289923
crossref_primary_10_1136_bmjopen_2024_093120
crossref_primary_10_1186_s12967_023_04068_9
crossref_primary_10_1016_j_ecoenv_2023_115277
crossref_primary_10_1016_j_tim_2022_01_013
crossref_primary_10_1128_mbio_03482_22
crossref_primary_10_1172_jci_insight_154344
crossref_primary_10_3389_fimmu_2024_1384137
crossref_primary_10_1016_j_blre_2024_101252
crossref_primary_10_1093_infdis_jiaa689
crossref_primary_10_1007_s00520_024_08776_w
crossref_primary_10_3324_haematol_2022_281309
crossref_primary_10_1097_SPC_0000000000000701
crossref_primary_10_1038_s41597_021_00860_8
crossref_primary_10_1056_NEJMoa1900623
crossref_primary_10_1051_parasite_2025011
crossref_primary_10_1200_JCO_22_02366
crossref_primary_10_1093_infdis_jiad190
crossref_primary_10_1038_s41467_022_28856_x
Cites_doi 10.1016/j.cmi.2014.11.022
10.1111/1574-6976.12075
10.1056/NEJMoa044097
10.5045/br.2016.51.2.102
10.1093/nar/gkt1274
10.1093/infdis/jix011
10.1084/jem.20181639
10.1093/cid/cis580
10.1038/nmeth.3869
10.1371/journal.pone.0061217
10.1182/blood-2014-02-554725
10.1093/cid/cir073
10.1371/journal.ppat.1005132
10.1093/cid/cix646
10.1016/S0022-2836(05)80360-2
10.1186/gb-2011-12-6-r60
ContentType Journal Article
Copyright The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020
Copyright_xml – notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
– notice: The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1093/cid/ciaa068
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
EndPage e4635
ExternalDocumentID PMC8662789
31976518
10_1093_cid_ciaa068
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA228308
– fundername: NIAID NIH HHS
  grantid: R01 AI137269
– fundername: NIH HHS
  grantid: U01 Al124275
– fundername: National Institute of Allergy and Infectious Diseases
– fundername: NCI NIH HHS
  grantid: P01 CA023766
– fundername: NIH HHS
  grantid: P30 CA008748
– fundername: NCI NIH HHS
  grantid: P30 CA008748
– fundername: NHLBI NIH HHS
  grantid: K08 HL143189
– fundername: ;
– fundername: ;
  grantid: U01 Al124275; R01 AI137269
– fundername: ;
  grantid: P30 CA008748
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
29B
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAVAP
AAYXX
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQKUS
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CITATION
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
J21
JLS
JSG
JXSIZ
KAQDR
KBUDW
KOP
KSI
KSN
L7B
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
RD5
ROX
ROZ
RUSNO
RW1
RXO
SJN
TCURE
TEORI
TJX
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
ADJQC
ADRIX
AEUPB
AFXEN
CGR
CUY
CVF
ECM
EIF
ESX
M49
NPM
7X8
5PM
AAUQX
ID FETCH-LOGICAL-c381t-ba428dd8b27e9afb0f016de32e2ec1fe4a3b0ffead783be3fc33ba247b9c972f3
ISSN 1058-4838
1537-6591
IngestDate Thu Aug 21 18:21:52 EDT 2025
Fri Jul 11 04:15:07 EDT 2025
Wed Feb 19 02:27:21 EST 2025
Tue Jul 01 01:18:20 EDT 2025
Thu Apr 24 23:05:45 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords intestinal microbiota
gram-negative bloodstream infections
allogeneic hematopoietic cell transplantation
Language English
License https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model
The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-ba428dd8b27e9afb0f016de32e2ec1fe4a3b0ffead783be3fc33ba247b9c972f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6601-8284
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/8662789
PMID 31976518
PQID 2344280039
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8662789
proquest_miscellaneous_2344280039
pubmed_primary_31976518
crossref_primary_10_1093_cid_ciaa068
crossref_citationtrail_10_1093_cid_ciaa068
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-06
PublicationDateYYYYMMDD 2021-12-06
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-06
  day: 06
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: US
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References McMurdie (2021121011154604400_CIT0011) 2013; 8
Stoma (2021121011154604400_CIT0001) 2016; 51
Taur (2021121011154604400_CIT0005) 2012; 55
Rajilić-Stojanović (2021121011154604400_CIT0013) 2014; 38
Tatusova (2021121011154604400_CIT0010) 2014; 42
Haak (2021121011154604400_CIT0004) 2018; 131
Sorbara (2021121011154604400_CIT0016) 2019; 216
Lee (2021121011154604400_CIT0006) 2017; 215
Bucaneve (2021121011154604400_CIT0015) 2005; 353
Taur (2021121011154604400_CIT0007) 2014; 124
Trecarichi (2021121011154604400_CIT0002) 2015; 21
Callahan (2021121011154604400_CIT0008) 2016; 13
Caballero (2021121011154604400_CIT0017) 2015; 11
Segata (2021121011154604400_CIT0012) 2011; 12
Averbuch (2021121011154604400_CIT0003) 2017; 65
Altschul (2021121011154604400_CIT0009) 1990; 215
Freifeld (2021121011154604400_CIT0014) 2011; 52
32572461 - Clin Infect Dis. 2021 Apr 8;72(7):1296-1297
References_xml – volume: 131
  start-page: 2978
  year: 2018
  ident: 2021121011154604400_CIT0004
  article-title: Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT
  publication-title: Blood
– volume: 21
  start-page: 337
  year: 2015
  ident: 2021121011154604400_CIT0002
  article-title: Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2014.11.022
– volume: 38
  start-page: 996
  year: 2014
  ident: 2021121011154604400_CIT0013
  article-title: The first 1000 cultured species of the human gastrointestinal microbiota
  publication-title: FEMS Microbiol Rev
  doi: 10.1111/1574-6976.12075
– volume: 353
  start-page: 977
  year: 2005
  ident: 2021121011154604400_CIT0015
  article-title: Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa044097
– volume: 51
  start-page: 102
  year: 2016
  ident: 2021121011154604400_CIT0001
  article-title: Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation
  publication-title: Blood Res
  doi: 10.5045/br.2016.51.2.102
– volume: 42
  start-page: D553
  year: 2014
  ident: 2021121011154604400_CIT0010
  article-title: RefSeq microbial genomes database: new representation and annotation strategy
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkt1274
– volume: 215
  start-page: 1117
  year: 2017
  ident: 2021121011154604400_CIT0006
  article-title: Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jix011
– volume: 216
  start-page: 84
  year: 2019
  ident: 2021121011154604400_CIT0016
  article-title: Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification
  publication-title: J Exp Med
  doi: 10.1084/jem.20181639
– volume: 55
  start-page: 905
  year: 2012
  ident: 2021121011154604400_CIT0005
  article-title: Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis580
– volume: 13
  start-page: 581
  year: 2016
  ident: 2021121011154604400_CIT0008
  article-title: DADA2: high-resolution sample inference from Illumina amplicon data
  publication-title: Nat Methods
  doi: 10.1038/nmeth.3869
– volume: 8
  start-page: e61217
  year: 2013
  ident: 2021121011154604400_CIT0011
  article-title: phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0061217
– volume: 124
  start-page: 1174
  year: 2014
  ident: 2021121011154604400_CIT0007
  article-title: The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2014-02-554725
– volume: 52
  start-page: e56
  year: 2011
  ident: 2021121011154604400_CIT0014
  article-title: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cir073
– volume: 11
  start-page: e1005132
  year: 2015
  ident: 2021121011154604400_CIT0017
  article-title: Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella pneumoniae
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1005132
– volume: 65
  start-page: 1819
  year: 2017
  ident: 2021121011154604400_CIT0003
  article-title: Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cix646
– volume: 215
  start-page: 403
  year: 1990
  ident: 2021121011154604400_CIT0009
  article-title: Basic local alignment search tool
  publication-title: J Mol Biol
  doi: 10.1016/S0022-2836(05)80360-2
– volume: 12
  start-page: R60
  year: 2011
  ident: 2021121011154604400_CIT0012
  article-title: Metagenomic biomarker discovery and explanation
  publication-title: Genome Biol
  doi: 10.1186/gb-2011-12-6-r60
– reference: 32572461 - Clin Infect Dis. 2021 Apr 8;72(7):1296-1297
SSID ssj0011805
Score 2.61213
Snippet Gram-negative bloodstream infections (BSIs) represent a significant complication facing allogeneic hematopoietic cell transplant (allo-HCT) recipients, as a...
In this study, the intestinal microbiota and risk of gram-negative bloodstream infections was studied in patients undergoing allogeneic hematopoietic cell...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e4627
SubjectTerms Bacteremia - microbiology
Gastrointestinal Microbiome
Gram-Negative Bacteria
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Online Only
Retrospective Studies
Sepsis - complications
Title Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria
URI https://www.ncbi.nlm.nih.gov/pubmed/31976518
https://www.proquest.com/docview/2344280039
https://pubmed.ncbi.nlm.nih.gov/PMC8662789
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkKa9IL4pA2SkPTGFNXE-H1nZ2IAiJFZpb5Xt2F2lJp1KKk38ffxhnD-TsD7AXqI0cW0l9_P5zvndHUIHJRgNImQyIFKo3SrJA5pnZRDHpIw5lYWQKsB58i09m8afL5PLweB3h7W0adh7_mtrXMldpArXQK4qSvY_JOs7hQtwDvKFI0gYjv8kYzWZLekK3vTpcnMDs7y5stRFtdkHE1jdmixMvqWGmoBExSdX_MJjRVtX4SK0guaGllXrPg4_rWkV1GJuEoMfm6TOtGvLjl1QpSN0bX667z3eUP_RrCptnp7PV54G_HXRNJUtznyimfytgl6azVe3qX849QShxZou9YoB6m1u2GNuuyIKNfUjbZ3b7WGQHQ08SvQOp1HKwmnlLEgTU9bLqW1TAcXBM-woYRGnJt-AXdHht0mJcmu5MKm0uIYHTAU6MiV-OtC5rvRNUFRZmtiVop-f-_tknKss-nlxD92PwFlRdTQ-nn_x37LCXBNp_YPZKFEY-whGPrLj7qFdN0jfRLrl9_xN3-3YQxcP0QPryOAPBpWP0EDUj9HuxFI1nqB1D5xYgRMbcGIAJ27BiVtwYgAnVuDEID7cASf24NR94B44sQPnUzQ9PbkYnwW2wEfAwVBsAkbB-S3LnEWZKKhkIwkOSClIJCLBQyliSuCaBGWX5YQJIjkhjEZxxgpeZJEkz9BOvarFC4Q5uN1ZScEfoEVc8jgfySRlRRSmOQMfSAzRO_dOZ9xmv1dFWJYzw8IgM1XC2spiiA5842uT9GV7s7dOODNQyupLG60FTLZZRGJ4MhX3PkTPjbB8R07KQ5T1xOgbqITv_Tv14konfrc4e3nnf-6jvXZOvkI7zXojXoNR3bA3GrN_AGFY2UI
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Compositional+Flux+Within+the+Intestinal+Microbiota+and+Risk+for+Bloodstream+Infection+With+Gram-negative+Bacteria&rft.jtitle=Clinical+infectious+diseases&rft.au=Stoma%2C+Igor&rft.au=Littmann%2C+Eric+R&rft.au=Peled%2C+Jonathan+U&rft.au=Giralt%2C+Sergio&rft.date=2021-12-06&rft.pub=Oxford+University+Press&rft.issn=1058-4838&rft.eissn=1537-6591&rft.volume=73&rft.issue=11&rft.spage=e4627&rft.epage=e4635&rft_id=info:doi/10.1093%2Fcid%2Fciaa068&rft_id=info%3Apmid%2F31976518&rft.externalDocID=PMC8662789
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon